Suprachoroidal drug delivery is a recent route for managing various ocular conditions. Safety and long term results are still under investigations.
In this study, we aim to analyze the long term results of suprachoroidal injection in treating various retinal diseases to focus on its efficacy, safety and long term ocular effects as ocular hypertension, cataract progression and macular edema resolution.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
100
Pars plana suprachoroidal injection of 4mg//0.1ml triamcinolone acetonide.
Ahmed Abdelshafy Tabl
Banhā, Benha, Egypt
RECRUITINGVisual acuity
Changes noted in vision after injection measured 8n logMar units by snellen chart.
Time frame: Baseline and up to one year after injection.
Central macular thickness
Changes noted in central macular thickness after injection measured by optical coherence tomography in microns.
Time frame: Baseline and up to one year after injection.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.